Search results for: “astrazeneca”
-
Oxford Biomedica Plc (LSE:OXB)
•
Oxford Biomedica Plc (LSE:OXB) is a leading, fully integrated, gene and cell therapy group focused on developing life…
-
Starpharma signs research agreement with MSD
•
MELBOURNE: Starpharma Holdings has signed a Research Agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth…
-
Starpharma Holdings Limited (ASX:SPL)
•
Click Here Starpharma Holdings Limited (ASX:SPL) share price Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company…
-
Insight — Pharmaceutical Sector Update
•
Vaccines, Trials and Promising Results Pakistan has had 535,914 reported cases of coronavirus to date of which 490,126…
-
Dr Anne Brindley appointment Chief Executive Officer of Nuformix plc
•
CAMBRIDGE: Nuformix plc announced the appointment of Dr Anne Brindley as Chief Executive Officer “CEO” and Executive Director…
-
Redx Pharma appoints leading oncology drug developer, Dr Jane Robertson, as Chief Medical Officer
•
ALDERLEY PARK: Redx Pharma plc has appointed Dr Jane Robertson as Chief Medical Officer, a news release noted.…
-
Novacyt Group
•
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom…
-
Just Group plc
•
Just Group plc, formerly JRP Group plc and, before that, Just Retirement Group plc, is a British company…
-
AHF asks Congress to hold pharma execs accountable on COVID vaccines
•
WASHINGTON: AIDS Healthcare Foundation (AHF) called on the members of the U.S. House of Representatives Subcommittee on Oversight…
-
Oxford Biomedica signs 5-year collaboration agreement with the Vaccines Manufacturing and Innovation Centre
•
OXFORD: Oxford Biomedica has signed a Collaboration Agreement with the Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit…
-
The US Oncology Network finds cancer drug may benefit advanced COVID-19 patients
•
HOUSTON: Rapid improvements have been seen in acutely ill patients with COVID-19 treated with the cancer drug acalabrutinib…
-
Bevespi Aerosphere approved in China for patients with COPD
•
LONDON: AstraZeneca’s Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in China as a maintenance treatment to relieve symptoms…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.